Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as Adjuvant Chemotherapy.
Victor MortierFelix WeiAnna PellatUgo MarcheseAnthony DohanCatherine BrezaultMaxime BaratDavid FuksPhilippe SoyerRomain CoriatPublished in: Cancers (2022)
Sarcopenia is associated with a worse prognosis in patients with localized operated PDAC whatever the delivered adjuvant chemotherapy.